Herbs (Global Traditional) · Traditional Chinese Medicine
Bupleurum (Bupleurum chinense) (Bupleurum chinense)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Bupleurum (Bupleurum chinense) is a traditional Chinese medicine herb containing bioactive saikosaponins that modulate immune function and inflammation. The primary saikosaponin compounds work through hepatoprotective and immunomodulatory mechanisms, particularly affecting cytokine production.
Bupleurum chinense (Chaihu) is a perennial herb in the Apiaceae family native to East Asia, with its dried roots serving as the primary medicinal part in Traditional Chinese Medicine. The roots are typically harvested, dried, and processed into decoctions, extracts, or powders using water decoction or ethanol extraction methods to obtain bioactive compounds like saikosaponins.
Limited high-quality human clinical trials exist for Bupleurum chinense alone. A double-blind RCT (n=48) tested a formula containing Bupleurum for Hashimoto's thyroiditis, showing 75% efficacy vs 46% placebo over 8 weeks (PMID: 36506504). Depression studies using proprietary formulas with Bupleurum showed efficacy in meta-analyses but with low evidence quality (PMID: 31328996; PMID: 9019785).
Clinical studies lack standardized standalone dosages for Bupleurum chinense, as trials primarily use it within traditional formulas without specifying isolated extract doses. Reviews note insufficient clinical data on optimal dosages or standardization. Consult a healthcare provider before starting any new supplement.
Bupleurum chinense root contains minimal macronutrients as it is used medicinally in small doses (typical dried root dose: 3–9g/day). Key bioactive compounds include: Saikosaponins (primary active constituents) at approximately 0.3–2.8% dry weight, comprising saikosaponin-a, -b1, -b2, -c, and -d — saikosaponin-a and -d are most pharmacologically active and show highest bioavailability when decocted in water at ~70–100°C; Polysaccharides (bupleuran 2IIb and related fractions) at approximately 3–8% dry weight, contributing to immunomodulatory effects; Flavonoids including rutin, isorhamnetin, and quercetin derivatives at approximately 0.1–0.5% dry weight; Lignans including bupleurumol at trace concentrations (<0.1% dry weight); Volatile oils (primarily caprylic acid, lauric acid, and myristic acid derivatives) at approximately 0.02–0.1% dry weight; Sterols including α-spinasterol and stigmasterol at approximately 0.05–0.2% dry weight; Polyacetylenes at trace levels. Mineral content includes selenium (concentration varies significantly by soil origin, estimated 0.01–0.05 mg/100g dry weight — relevant to reported hepatoprotective selenium-enhancement mechanisms), potassium (~200–400 mg/100g dry weight), calcium (~100–200 mg/100g dry weight), and magnesium (~50–100 mg/100g dry weight). Crude fiber content is approximately 20–35% dry weight, primarily insoluble. Protein content is approximately 8–12% dry weight but nutritionally irrelevant at medicinal doses. Bioavailability note: Saikosaponins undergo significant hydrolysis during hot-water decoction, converting saikosaponin-a/-d to more bioavailable prosaikogenins; oral bioavailability of intact saikosaponins is low (~5–15%) due to gut microbial metabolism, though metabolites retain activity. Co-administration with licorice root (as in traditional formulas) may enhance absorption via P-glycoprotein inhibition.
Bupleurum's primary bioactive compounds, saikosaponins A and D, modulate immune function by regulating T-helper cell differentiation and reducing pro-inflammatory cytokines like TNF-α and IL-6. These triterpene saponins also activate peroxisome proliferator-activated receptors (PPARs) and inhibit nuclear factor-kappa B (NF-κB) signaling pathways. Additionally, saikosaponins demonstrate hepatoprotective effects by reducing oxidative stress and supporting liver cell regeneration through mitochondrial protection mechanisms.
A small randomized controlled trial (n=48) demonstrated 75% clinical efficacy for Hashimoto's thyroiditis when bupleurum was used in traditional formulas, representing moderate-quality evidence. Meta-analyses of traditional Chinese medicine formulas containing bupleurum show potential antidepressant effects, though the evidence quality remains low due to study heterogeneity and small sample sizes. Most clinical research focuses on bupleurum as part of multi-herb formulations rather than as an isolated compound. Additional studies are needed to establish optimal dosing protocols and confirm individual herb efficacy versus formula synergies.
Bupleurum is generally well-tolerated but may cause gastrointestinal upset, dizziness, or sedation in some individuals. The herb may interact with immunosuppressive medications due to its immune-modulating effects, requiring medical supervision for autoimmune conditions. Bupleurum can potentially enhance the effects of sedative medications and should be used cautiously with CNS depressants. Pregnancy and breastfeeding safety has not been established, so use should be avoided during these periods without professional guidance.
